Inventor · disambiguated record
Giuseppe Alvaro
Also filed as: ALVARO GIUSEPPE
60 granted patents·28 pending applications·313 citations·filing 2000–2025
99Inventor score
Files withAUTIFONY THERAPEUTICS LTD30ALVARO GIUSEPPE26GLAXO GROUP LTD13SMITHKLINE BEECHAM CORP7GLAXOSMITHKLINE LLC3
Top patents by PatentIndex Score
88 records- 0195US10835534B2CompoundsAUTIFONY THERAPEUTICS LTD·Filed 2019·Granted Nov 17, 2020·3 cites·4 claims
- 0295US9422272B2CompoundsAUTIFONY THERAPEUTICS LTD·Filed 2015·Granted Aug 23, 2016·11 cites·2 claims
- 0395US9133175B2CompoundsAUTIFONY THERAPEUTICS LTD·Filed 2012·Granted Sep 15, 2015·18 cites·10 claims
- 0494US11944623B2Modulators of Kv3 channels to treat painAUTIFONY THERAPEUTICS LTD·Filed 2021·Granted Apr 2, 2024·2 cites·20 claims
- 0594US10098881B2CompoundsAUTIFONY THERAPEUTICS LTD·Filed 2017·Granted Oct 16, 2018·8 cites·14 claims
- 0693US9833452B2CompoundsAUTIFONY THERAPEUTICS LTD·Filed 2016·Granted Dec 5, 2017·7 cites·1 claims
- 0793US9346790B2Hydantoin derivatives useful as Kv3 inhibitorsALVARO GIUSEPPE·Filed 2011·Granted May 24, 2016·16 cites·18 claims
- 0893US7683056B2Pyridine derivatives and their use in the treatment of psychotic disordersGLAXOSMITHKLINE LLC·Filed 2006·Granted Mar 23, 2010·19 cites·12 claims
- 0991US6642240B2Treating emesis in a mammalSMITHKLINE BEECHAM CORP·Filed 2002·Granted Nov 4, 2003·31 cites·31 claims
- 1090US7655693B2CompoundsGLAXO GROUP LTD·Filed 2006·Granted Feb 2, 2010·14 cites·14 claims
- 1189US8722695B2Imidazolidinedione derivativesALVARO GIUSEPPE·Filed 2010·Granted May 13, 2014·9 cites·16 claims
- 1288US10555945B2CompoundsAUTIFONY THERAPEUTICS LTD·Filed 2018·Granted Feb 11, 2020·3 cites·17 claims
- 1388US8093268B2Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-)ALVARO GIUSEPPE·Filed 2008·Granted Jan 10, 2012·12 cites·4 claims
- 1488US7855218B2CompoundsCONVERGENCE PHARMACEUTICALS·Filed 2006·Granted Dec 21, 2010·13 cites·16 claims
- 1587US9849131B2Imidazolidinedione derivativesAUTIFONY THERAPEUTICS LTD·Filed 2016·Granted Dec 26, 2017·4 cites·19 claims
- 1687US8153681B2Method of treating epilepsy by administering 5-(4{[(2-fluorophenyl)methyl]oxy}phenyl)prolinamideALVARO GIUSEPPE·Filed 2009·Granted Apr 10, 2012·9 cites·8 claims
- 1787US7294630B2Piperazinyl piperidine tachykinin antagonistsSMITHKLINE BEECHAM CORP·Filed 2006·Granted Nov 13, 2007·6 cites·3 claims
- 1886US11197859B2Hydantoin derivatives useful as Kv3 inhibitorsAUTIFONY THERAPEUTICS LTD·Filed 2020·Granted Dec 14, 2021·1 cites·16 claims
- 1986US9216967B2Imidazolidinedione derivativesAUTIFONY THERAPEUTICS LTD·Filed 2014·Granted Dec 22, 2015·5 cites·7 claims
- 2086US7803833B2CompoundsGLAXO GROUP LTD·Filed 2006·Granted Sep 28, 2010·10 cites·22 claims
- 2185US10058551B2Imidazolidinedione derivativesAUTIFONY THERAPEUTICS LTD·Filed 2017·Granted Aug 28, 2018·3 cites·12 claims
- 2285US8129384B2Imidazo[1,2-a]pyrazines as orexin receptor antagonistsALVARO GIUSEPPE·Filed 2009·Granted Mar 6, 2012·7 cites·17 claims
- 2385US8093255B2Imidazo[1,2-A]pyrimidines as orexin receptor antagonistsALVARO GIUSEPPE·Filed 2009·Granted Jan 10, 2012·8 cites·17 claims
- 2484US9422252B2Triazoles as Kv3 inhibitorsAUTIFONY THERAPEUTICS LTD·Filed 2013·Granted Aug 23, 2016·5 cites·5 claims
- 2584US8153623B2CompoundsALVARO GIUSEPPE·Filed 2010·Granted Apr 10, 2012·9 cites·18 claims
- 2684US8143306B2Methods of treating bipolar disordersALVARO GIUSEPPE·Filed 2011·Granted Mar 27, 2012·8 cites·12 claims
- 2784US7919491B2Pyridine derivatives and their use in the treatment of psychotic disordersGLAXOSMITHKLINE LLC·Filed 2009·Granted Apr 5, 2011·4 cites·6 claims
- 2883US9193704B2Hydantoin derivatives as KV3 inhibitorsALVARO GIUSEPPE·Filed 2012·Granted Nov 24, 2015·6 cites·11 claims
- 2983US8344005B25-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoMethylpropanoylmethylamino]-4-(4-fluoro-2-methylphenyl)]-2 as NK1 receptor antagonistsGLAXO WELLCOME MFG PTE LTD·Filed 2009·Granted Jan 1, 2013·5 cites·5 claims
- 3082US8133908B2Heteroaryl derivatives of N-{[(1S,4S,6S)-3-(2-pyridinylcarbonyl)-3-azabicyclo[4.1.0]hept-4-yl]methyl}-2-amineALVARO GIUSEPPE·Filed 2009·Granted Mar 13, 2012·10 cites·16 claims
- 3181US11147813B2Modulators of KV3 channels to treat painAUTIFONY THERAPEUTICS LTD·Filed 2016·Granted Oct 19, 2021·2 cites·11 claims
- 3281US2025017925A1Modulators of kv3 channels to treat painAUTIFONY THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 3380US11583527B2Hydantoin derivatives useful as Kv3 inhibitorsAUTIFONY THERAPEUTICS LTD·Filed 2021·Granted Feb 21, 2023·0 cites·18 claims
- 3480US10265316B2Hydantoin derivatives useful as Kv3 inhibitorsAUTIFONY THERAPEUTICS LTD·Filed 2017·Granted Apr 23, 2019·1 cites·3 claims
- 3580US6951861B1Chemical compoundsSMITHKLINE BEECHAN CORP·Filed 2000·Granted Oct 4, 2005·15 cites·102 claims
- 3679US7345041B2Chemical compoundsSMITHKLINE BEECHAM CORP·Filed 2006·Granted Mar 18, 2008·2 cites·3 claims
- 3778US8097618B2Pyridine derivatives and their use in the treatment of psychotic disordersALVARO GIUSEPPE·Filed 2011·Granted Jan 17, 2012·3 cites·6 claims
- 3877US11541052B2CompoundsAUTIFONY THERAPEUTICS LTD·Filed 2020·Granted Jan 3, 2023·0 cites·7 claims
- 3976US7652012B22-(R)-(4-fluoro-2-methyl-phenyl)-4-(S)-((8aS)-6-oxo-hexahydro-pyrrolo[1,2-a]-pyrazin-2-yl)-piperidine-1-carboxylic acid [1-(R)-3,5-bis-trifluoromethyl-phenyl)-ethyl]-methylamide maleate and pharmaceutical compositions thereofGLAXO GROUP LTD·Filed 2006·Granted Jan 26, 2010·2 cites·2 claims
- 4074US7534893B2Imidazol-2-one compounds useful in the treatment of various disordersGLAXO GROUP LTD·Filed 2005·Granted May 19, 2009·5 cites·10 claims
- 4173US11180461B2Triazoles as Kv3 inhibitorsAUTIFONY THERAPEUTICS LTD·Filed 2020·Granted Nov 23, 2021·0 cites·5 claims
- 4271US12358901B2KV3 modulatorsAUTIFONY THERAPEUTICS LTD·Filed 2021·Granted Jul 15, 2025·0 cites·3 claims
- 4371US2025304564A1Novel kv3 modulatorsAUTIFONY THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 4470US2020163964A1Imidazolidinedione derivativesAUTIFONY THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 4570US2019192516A1Hydantoin derivatives useful as kv3 inhibitorsAUTIFONY THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 4669US7119092B2Chemical compoundsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Oct 10, 2006·3 cites·41 claims
- 4769US7060702B2Chemical compoundsSMITHKLINE BEECHAM CORP·Filed 2004·Granted Jun 13, 2006·3 cites·79 claims
- 4868US10611735B2Triazoles as Kv3 inhibitorsAUTIFONY THERAPEUTICS LTD·Filed 2018·Granted Apr 7, 2020·0 cites·5 claims
- 4968US7648990B2Chemical compoundsGLAXOSMITHKLINE LLC·Filed 2007·Granted Jan 19, 2010·1 cites·67 claims
- 5068US7071196B2Chemical compoundsSMITHKLINE BEECHAM CROP·Filed 2003·Granted Jul 4, 2006·4 cites·18 claims
Showing the top 50 of 88 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Giuseppe Alvaro files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →